4//SEC Filing
Sandrock Alfred 4
Accession 0001127602-21-007000
CIK 0000875045other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:19 PM ET
Size
9.9 KB
Accession
0001127602-21-007000
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Sandrock Alfred
Grp SVP, Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2021-02-18+14,500→ 14,500 totalExercise: $0.00Exp: 2024-02-18→ Common Stock (14,500 underlying)
Footnotes (1)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001577061
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:19 PM ET
- Size
- 9.9 KB